Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Shingrix expired dose; received first dose of Shingrix on February 4, 2021 and second dose (expired dose) on July 15, 2025.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 56-year-old male patient who received Herpes zoster (Shingrix) (expiry date 13-JUL-2025) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 04-FEB-2021). On 15-JUL-2025, the patient received the 2nd dose of Shingrix. On 15-JUL-2025, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Shingrix expired dose) and drug dose administration interval too long (Verbatim: received first dose of Shingrix on February 4, 2021 and second dose (expired dose) on July 15, 2025.). The outcome of the expired vaccine used and drug dose administration interval too long were not applicable. Additional Information: GSK Receipt Date: 16-JUL-2025 The reporter reported that a patient received an expired dose of the Shingrix vaccine and while gathering details of this event it was discovered that the dose would also be a late second dose, which led to drug dose administration interval too long. The reporter stated a patient received the first dose of Shingrix on 4th February 2021 and then the second dose (expired dose) on 15th July 2025, which led to expired vaccine used.